Add the following to the start of the IG's home page: 1.1 Overview. Add "consent" to the following sentence (italicized below)... This FHIR implementation Guide describes the exchange of patient demographic, clinical, consent and coverage data to support fulfillment of specialty medication prescriptions  1.2 Background. Add the italicized content below... Specialty medications are generally defined as those of high cost or requiring special handling. The use of these medications may be constrained based on indication for use, risks to patient health vs. potential benefits, cost, etc.   There can be different settings for administration as well as limitations on where they can be dispensed.  Additional steps in the prescribing and dispensing process may exist, including the need to share consent information. Consent may be needed to authorize contact by patient support programs, sharing of patient clinical and other information to support steps to obtain insurance coverage or other financial support, etc. The current process for exchanging information to support specialty medication fulfillment is complex and manual, often resulting in delays of days to weeks before patients can begin their therapy. This is caused largely by the absence of an industry standard for exchanging clinical and administrative data needed to dispense specialty medications and enroll the patient into associated support and savings programs. 1.3 Scope of This Guide. Add "such as consent" to the second bullet... This guide addresses the exchange of information to support specialty medication fulfillment functions, including: medication dispensing and billing specialty enrollment for programs or services , such as consent ...